Transmission of the hepatitis B virus-associated delta antigen to chimpanzees.
Inoculation of hepatitis B surface antigen (HBsAg)-positive sera from patients with chronic liver disease and intrahepatic delta (delta) into chimpanzees susceptible to infection with hepatitis B virus (HBV) resulted in type B hepatitis and delta markers (delta antigen and antibody to delta) in recipient animals. A dilution (10(-8)) of serum induced type B hepatitis without delta markers in another HBV-susceptible animal. HBV infection and delta markers did not develop in animals with preexisting titers of antibody of HBsAg. In chimpanzees with circulating HBsAg at the time of inoculation, synthesis of delta occurred earlier and its extent and duration were greater than in animals previously unexposed to HBV; coincident with synthesis of delta, hepatitis occurred in chronic HBsAg carriers, and synthesis of preexisting HBV gene products (HBsAg and hepatitis B core antigen) was diminished. Delta appears to be a marker of a transmissible pathogenic agent, either an HBV variant or another agent that requires the helper functions of HBV, that is defective and interferes with HBV replication.
D000818:Animals; D004259:DNA-Directed DNA Polymerase / Q000378:metabolism; D005455:Fluorescent Antibody Technique; D006509:Hepatitis B / Q000635:transmission*; D006511:Hepatitis B Antigens / Q000008:administration & dosage; D006514:Hepatitis B Surface Antigens / Q000008:administration & dosage; D006801:Humans; D008099:Liver / Q000382:microbiology / Q000648:ultrastructure; D008854:Microscopy, Electron; D002679:Pan troglodytes
D006511:Hepatitis B Antigens; D006514:Hepatitis B Surface Antigens; D004259:DNA-Directed DNA Polymerase